Clinical Toxicology/Drugs of Abuse Committee

Last Updated: Wednesday, 27 February 2019 15:47

	Chair Manuela Neuman Toronto, ON, Canada	Contact Us Scientific Committees Clinical Toxicology/DOA Committee
	Vice-Chair Katharina Rentsch Basel, Switzerland

Background & Purpose of the Committee

To promote and advance the discipline of Clinical Toxicology within the Association by:

• Developing relevant practice guidelines, when appropriate, in particular fields of clinical toxicology and drugs of abuse testing;
• Publishing articles and other professional notes in the field of clinical toxicology and drugs of abuse in the Newsletter and on the web page;
• Assist in the holding of specialist workshops and symposia at the IATDMCT Congresses;
• Developing links and partnerships with other relevant professional societies; and
• Attracting new members to the Association with interests in clinical toxicology and drugs of abuse.

Committee Initiatives for 2018/2019

Contributions to Compass:

• March 2018: KRATOM – IS IT A CURE FOR OPIOID ADDICTION AND CHRONIC PAIN OR IS IT A DANGEROUS DRUG?
  By Kamisha L. Johnson-Davis. University of Utah, Department of Pathology, Utah, United States of America

• June 2018: CLINICAL TOXICOLOGY AT THE INTERFACE BETWEEN NOVEL DRUGS OF ABUSE AND NOVEL TECHNOLOGIES
  By Cristiana Stefan, Centre for Addiction and Mental Health, Toronto, ON, Canada

• September 2018: CANNABIS CONTROVERSY IN EPILEPSY
  By Manuela G. Neuman. In Vitro Drug Safety and Biotechnology, University of Toronto, Toronto, Canada

• 2019 - Is Gabapentin (Neurontin) Misuseon your radar?
  By Kamisha L. Johnson-Davis. University of Utah, Department of Pathology, Utah, United States of America

Committee Initiatives Completed in 2016/2017

Contributions to Compass (2017)

• December : ALCOHOL MISUSE CLINICAL TOXICOLOGY, MEDICAL AND TRANSLATIONAL RESEARCH
  By Manuela G. Neuman, Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada

• September: CLINICAL TOXICOLOGY IN CHINA:  CURRENT SITUATION AND CHALLENGES
  By Shusen Sun, PharmD, BCPS College of Pharmacy and Health Sciences, Western New England University

• June : CLINICAL AND FORENSIC TOXICOLOGY IN THE NETHERLANDS
  By Annabel Werumeus Buning, Eric J.F. Franssen Department of Clinical Pharmacy and Toxicology, Onze Lieve Vrouwe Gasthuis, Amsterdam

• March: MEDICAL CANNABIS – The PLANT OF MANY WONDERS
  By Kamisha L. Johnson-Davis. University of Utah, Department of Pathology, Utah, United States of America.

Also we congratulate
Alain.Verstraete for receiving the highest recognition in toxicology:
Sunshine Award

Additional Committee Resources

Items marked with an * are Member Only, login required.

• Compass Extracts*